Technical Resources International Inc. (TRI): Exceeding Expectations in Clinical Research

Technical Resources International Inc. (TRI): Exceeding Expectations in Clinical Research

Follow Technical Resources International Inc. (TRI) on :

The complexity and cost of clinical studies continue to rise. These demands require commitments from all stakeholders including contract research organizations (CROs) and trial sponsors. In order to leverage economic and efficiency gains, public and private sector sponsors partner with CROs to maintain high operational and quality standards. Technical Resources International Inc. (TRI), a front runner of clinical research having navigated the drug development space with a legacy spanning 40 years. The organization was founded in 1979 as a minority-owned company under Anthony Lee and has since grown into a full-service minority and woman-owned CRO with President and CEO Nora Lee at the helm. TRI offers product development services to the global biologic, drug, and medical device community through an effective combination of scientific, clinical, information technology, and communication services.

TRI’s clinical research services include biostatistics, clinical operations, data analytics and visualization, data management, medical writing, next genome sequencing, regulatory affairs, safety and pharmacoviglance, and quality assurance. The organization provides critical technical assistance to government and private sector sponsors. With an unmatched track record and years of experience, the company adapts itself as a seasoned contractor. TRI’s global footprint and client-first approach fuel its long-term relationships with clients.

Unlike other CROs, TRI’s uniqueness stems from the diverse range of services it offers. TRI’s communication services include offerings from strategic development through plan implementation. Specifically, these services include event planning and management, advertising and public relations, market research, multi-media design and production, and training. These communication services combined with experienced medical and technical writers and clinical research operation specialists allows TRI to deliver value add to its clients in the form of strategic planning, participant recruitment, and retention plans, the development and execution of scientific and medical meetings including investigator meetings, site staff training programs, and product launches.

The company’s competitive edge can also be attributed to its IT services. In addition to clinical and communication services, TRI’s IT division provides mission-critical support for its clients.

As a consulting partner, we support clients in our provision of insight and analysis to best position their long-term vision and program development and implementation.

These include systems integration through clinical data management systems, pharmacovigilance, and drug safety systems, document and content management, regulatory publishing and submission, and clinical management portal development and collaboration. The organization provides custom application development and business intelligence for clinical research. TRI provides validation of regulated clinical systems with a focus on 21 CFR Part 11 compliance. Finally, TRI offers clinical system best practice consulting to ensure the architecture, code, and system are properly designed, built, and documented.

As TRI has witnessed the ever-evolving challenges and trends in the industry, it continues to develop systems and processes to manage risk and maintain relevancy. TRI stays at the forefront through the knowledge and experience acquired over the years integrated with its top talent and technology. Through the understanding of domestic and global requirements and the commitment toward innovative solutions, TRI supports clients in solving unique challenges. Nora shares, “As a consulting partner, we support clients in our provision of insight and analysis best positioning their long-term vision and program development and implementation.”
Share this Article: